AAAAAA

   
Results: 1-9 |
Results: 9
Mullerian inhibiting substance inhibits testosterone synthesis in adult rats
Authors: Sriraman, V Niu, E Matias, JR Donahoe, PK MacLaughlin, DT Hardy, MP Lee, MM
Citation: V. Sriraman et al., Mullerian inhibiting substance inhibits testosterone synthesis in adult rats, J ANDROLOGY, 22(5), 2001, pp. 750-758
Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo
Authors: Stephen, AE Masiakos, PT Segev, DL Vacanti, JP Donahoe, PK MacLaughlin, DT
Citation: Ae. Stephen et al., Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo, P NAS US, 98(6), 2001, pp. 3214-3219
Mullerian inhibiting substance regulates NF kappa B signaling and growth of mammary epithelial cells in vivo
Authors: Segev, DL Hoshiya, Y Stephen, AE Hoshiya, M Tran, TT MacLaughlin, DT Donahoe, PK Maheswaran, S
Citation: Dl. Segev et al., Mullerian inhibiting substance regulates NF kappa B signaling and growth of mammary epithelial cells in vivo, J BIOL CHEM, 276(29), 2001, pp. 26799-26806
Perspective: Reproductive tract development - New discoveries and future directions
Authors: MacLaughlin, DT Teixeira, J Donahoe, PK
Citation: Dt. Maclaughlin et al., Perspective: Reproductive tract development - New discoveries and future directions, ENDOCRINOL, 142(6), 2001, pp. 2167-2172
A time-less function for mouse Timeless
Authors: Gotter, AL Manganaro, T Weaver, DR Kolakowski, LF Possidente, B Sriram, S MacLaughlin, DT Reppert, SM
Citation: Al. Gotter et al., A time-less function for mouse Timeless, NAT NEUROSC, 3(8), 2000, pp. 755-756
Mullerian inhibiting substance inhibits breast cancer cell growth through an NF kappa B-mediated pathway
Authors: Segev, DL Ha, TU Tran, TT Kenneally, M Harkin, P Jung, M MacLaughlin, DT Donahoe, PK Maheswaran, S
Citation: Dl. Segev et al., Mullerian inhibiting substance inhibits breast cancer cell growth through an NF kappa B-mediated pathway, J BIOL CHEM, 275(37), 2000, pp. 28371-28379
Human ovarian cancer, cell lines, and primary ascites cells express the human mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS
Authors: Masiakos, PT MacLaughlin, DT Maheswaran, S Teixeira, J Fuller, AF Shah, PC Kehas, DJ Kenneally, MK Dombkowski, DM Ha, TU Preffer, FI Donahoe, PK
Citation: Pt. Masiakos et al., Human ovarian cancer, cell lines, and primary ascites cells express the human mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS, CLIN CANC R, 5(11), 1999, pp. 3488-3499
The type I serine threonine kinase receptor ActRIA (ALK2) is required for gastrulation of the mouse embryo
Authors: Gu, ZY Reynolds, EM Song, JH Lei, H Feijen, A Yu, LA He, WW MacLaughlin, DT van den Eijnden-van Raaij, J Donahoe, PK Li, E
Citation: Zy. Gu et al., The type I serine threonine kinase receptor ActRIA (ALK2) is required for gastrulation of the mouse embryo, DEVELOPMENT, 126(11), 1999, pp. 2551-2561
Diagnostic utility of Mullerian inhibiting substance determination in patients with primary and recurrent granulosa cell tumors
Authors: Lane, AH Lee, MM Fuller, AF Kehas, DJ Donahoe, PK MacLaughlin, DT
Citation: Ah. Lane et al., Diagnostic utility of Mullerian inhibiting substance determination in patients with primary and recurrent granulosa cell tumors, GYNECOL ONC, 73(1), 1999, pp. 51-55
Risultati: 1-9 |